PPARA and Cerebral ischemia: Because EC loss and subsequent vasoregression contribute to neurodegeneration in cerebral ischemia, DR, peripheral neuropathy, and age-related neurodegenerative diseases [75], it is likely that PPARα-mediated vasoprotection contributes to the observed neuroprotective effects in these models.